[Federal Register Volume 67, Number 69 (Wednesday, April 10, 2002)]
[Notices]
[Page 17467]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-8668]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 23, 2001, B.I. 
Chemical, Inc., which has changed its name to Boehringer Ingelheim 
Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, 
made application by letter to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of fentanyl (9801), a basic 
class of controlled substance listed Schedule II.
    The firm plans to bulk manufacture the listed controlled substance 
for sale to their customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than June 10, 2002.

    Dated: March 27, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-8668 Filed 4-9-02; 8:45 am]
BILLING CODE 4410-09-M